Exploring Appropriate Reference Intervals and Clinical Decision Limits for Glucose-6-Phosphate Dehydrogenase Activity in Individuals From Guangzhou, China.
Zhenyi HuangZiyan LiYating LiYunshan CaoSuping ZhongJinlu LiuZhiqian LinLijuan LinYanping FangJing ZengZhaoying SuHuibin LiJianfen LiangBiqing ZhuZipei LinYong-Xin HuangXue-Xi YangLingxiao JiangPublished in: Annals of laboratory medicine (2024)
variants and hemolysis risk enables improved prediction and management of G6PD deficiency, ultimately enhancing patient care and treatment outcomes.